Activated protein C resistance in patients with arterial ischemic stroke

Journal of Stroke and Cerebrovascular Diseases

Volumn 10, Issue 3, 2001, Pages 128-131

  Rey, Raul C ^a,b   De Larrañaga, Gabriela ^a,b   Lepera, Sandra ^a,b   Cohen, Marcela ^a,b   Saposnik, Gustavo ^a,b   Alonso, Beatriz ^a,b   Sica, Roberto E P ^a,b  

^a HOSPITAL RAMOS MEJÍA   (Argentina)

^b HOSPITAL F J MUÑIZ   (Argentina)

Author keywords

Activated protein C resistance; Factor V Leiden; Ischemic stroke; Thrombophilia

Indexed keywords

PROTEIN C;

ADULT; AGED; ARGENTINA; ARTICLE; BRAIN ISCHEMIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; STROKE; THROMBOPHILIA;

EID: 0034928396     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1053/jscd.2001.25464     Document Type: Article

References (29)

1. Anticoagulant properties of bovine plasma protein C following activation by thrombin
2. Factor VIII structure and function
3. Familial thrombophilia due to a previously unrecogmized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C
4. Mutation in blood coagulation factor V associated with resistance to activated protein C
5. A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype
6. Activated protein C resistance; molecular mechanism
7. The influence of FVIII on measurement of activated protein C resistance
8. Resistance to the activated protein C and factor V Leiden as risk factor for venous thrombosis
9. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study
10. Evaluation of original and modified APC-resistance test in unselected outpatients with clinically suspected thrombosis and in healthy controls
11. Cerebral venous thrombosis and activated protein C resistance
12. Cerebral venous thrombosis: Role of activated protein C resistance and factor V gene mutation
13. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis
14. The prevalence of poor anticoagulant response to activated protein C (APC resistence) among patients suffering from stroke or venous thrombosis and among healthy subjects
15. Plasma resistance to activated protein C in venous and arterial thrombosis
16. Cerebrovascular disease in the community: Results of a WHO collaborative study
17. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment
18. Acquired activated protein C-resistance in patients with lupus anticoagulants
19. False positive activated protein C resistance test due to anti-phospholipid antibodies is corrected by platelet extract
20. Complete discrimination for FV:Q506 in plasma from OAC-patients, heparin patients and non-treated individuals using Coatest APC resistance assay after predilution in V-DEF plasma
21. Sensitivity and specifity of the APC resistance assay in detection of individuals with factor V Leiden
22. Resistance to activated protein C, the Arg506 to Gin mutation in the factor V gene and venous thrombosis
23. F V Leiden mutation in the Argentinian population
24. Ischemic stroke in young patients with activated protein C resistance
25. Ischaemic stroke in infancy and chilhood: Role of the Arg 506 to Gln mutation in the factor V gene
26. Ischemic stroke in the elderly: Role of the common factor V mutation causing resistance to activated protein C
27. Factor V Leiden, prothrombin 203106-A and the MTHFR C677T mutations in chilhood stroke
28. Activated protein C resistance in ischemic stroke not due to factor V arginine506-glutamine mutation
29. Mutation in gene coding for coagulation factor V and risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men